Varicose Veins
Conditions
Interventions
Fifty-six lower limbs will be randomized for treatment and allocated into two treatment protocols: Transdermal laser with fixed parameters combined with sclerotherapy using 75% glucose, and sclerother
Sponsors
Universidade do Vale do Rio dos Sinos
Clinica Prime Vascular
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women; aged between 18 and 70 years; reticular veins and telangiectasias; without reflux of the deep venous or saphenous system; Fitzpatrick Skin Type I, II or III; Patients should have at least one reticular vein with a minimum length of 5 cm in one of the lower limbs on the lateral side of the thigh
Exclusion criteria
Exclusion criteria: Venous disease CEAP class greater than C1; who underwent procedure with sclerotherapy or transdermal laser in the last 12 months; skin classification Fitzpatrick IV, V or VI; pregnancy or puerperium; known allergy; peripheral arterial disease; diabetes; dermatitis at the treatment site; asthma; migraine; deep or superficial deep vein thrombosis (DVT); family history of DVT; known thrombophilia or any hypercoagulable state and use of anticoagulants; uncontrolled systemic disorders; patients who fail to attend their treatment sessions or follow-up visits
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1:It is expected to find disappearance of the reticular vein and the clearing of the telangiectasia veins in the treatment area after 30 days of treatment, verified by means of photographs, with the use of transdermal laser associated with the sclerosing solution. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes expected | — |
Countries
Brazil
Contacts
Public ContactMarcos Fonseca
Clinica Prime Vascular
Outcome results
None listed